Individualized management of pregnant women with high hepatitis B virus DNA levels

World Journal of Gastroenterology

Volumn 20, Issue 34, 2014, Pages 12056-12061

  Zhang, Zhao ^a   Chen, Chao ^b   Li, Zhe ^a   Wu, Ying Hua ^a   Xiao, Xiao Min ^a  

^a JINAN UNIVERSITY   (China)

^b Zhuhai Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Hepatitis B virus; Hepatitis B virus DNA; High level; Management; Pregnancy

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; VIRUS DNA; BIOLOGICAL MARKER; HEPATITIS B HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN;

ANTIVIRAL THERAPY; BREAST FEEDING; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; META ANALYSIS; PREGNANT WOMAN; PRENATAL PERIOD; PRENATAL SCREENING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VIREMIA; BLOOD; DRUG EFFECTS; GENETICS; HEPATITIS B, CHRONIC; PATHOGENICITY; PATIENT SELECTION; PREDICTIVE VALUE; PREGNANCY; PRENATAL DIAGNOSIS; PREVENTION AND CONTROL; RISK FACTOR; TRANSMISSION; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIROLOGY; VIRUS LOAD;

BIOLOGICAL MARKERS; DNA, VIRAL; FEMALE; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULINS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84909588702     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i34.12056     Document Type: Review

References (55)

1. Mohamed R, Desmond P, Suh DJ, Amarapurkar D, Gane E, Guangbi Y, Hou JL, Jafri W, Lai CL, Lee CH, Lee SD, Lim SG, Guan R, Phiet PH, Piratvisuth T, Sollano J, Wu JC. Practical difficulties in the management of hepatitis B in the Asia-Pacific region. J Gastroenterol Hepatol 2004; 19: 958-969 [PMID: 15304110]
2. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, Lin CY, Bai HQ, Yan J, Cui G, Yu JJ. [A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old]. Zhonghua Liu Xing Bing Xue Zazhi 2005; 26: 655-658 [PMID: 16471211 DOI: 10.3760/j.issn:0254-6450.2005.09.008]
3. Chinese Center for Disease Control and Prevention, Ministry of Health of the People's Republic of China. The report of hepatitis B epidemiological investigation. Beijing: People's Medical Publishing House, 2011
4. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 10: 3215-3217 [PMID: 15457579]
5. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004; 351: 2832-2838 [PMID: 15625334 DOI: 10.1056/NEJMcp041507]
6. Karayiannis P, Main J, Thomas HC. Hepatitis vaccines. Br Med Bull 2004; 70: 29-49 [PMID: 15339856 DOI: 10.1093/bmb/ldh024]
7. Ranger-Rogez S, Denis F. Hepatitis B mother-to-child transmission. Expert Rev Anti Infect Ther 2004; 2: 133-145 [PMID: 15482178 DOI: 10.1586/14787210.2.1.133]
8. Centers for Disease Control and Prevention (CDC). Hepatitis B vaccination - United States, 1982-2002. MMWR Morb Mortal Wkly Rep 2002; 51: 549-52, 563 [PMID: 12118536]
9. Buchanan C, Tran TT. Management of chronic hepatitis B in pregnancy. Clin Liver Dis 2010; 14: 495-504 [PMID: 20638027 DOI: 10.1016/j.cld.2010.05.008]
10. Chang MH. Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants. Antivir Ther 2010; 15: 463-469 [PMID: 20516566 DOI: 10.3851/IMP1555]
11. Chang MH. Cancer prevention by vaccination against hepatitis B. Recent Results Cancer Res 2009; 181: 85-94 [PMID: 19213561]
12. Wang F, Han GR, Li FZ, Xue YZ. Study on the relationship between neonatal intrauterine infection and maternal HBV makers and HBV DNA levels. Zhongguo Xiandai Yixue Zazhi 2009; 37: 435-437
13. del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, de Gast GC, Fetter WP, Zwijneberg J, Schalm SW. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15: 1624-1630 [PMID: 9364693 DOI: 10.1016/S0264-410X(97)00080-7]
14. Yin YZ, Chen XW, Li XM, Hou HY, Shi ZJ. [Intrauterine HBV infection: risk factors and impact of HBV DNA]. Nan Fang Yi Ke Da Xue Xuebao 2006; 26: 1452-1454 [PMID: 17062350 DOI: 10.3321/j.issn:1673-4254.2006.10.033]
15. Cowan SA, Bagdonaite J, Qureshi K. Universal hepatitis B screening of pregnant women in Denmark ascertains substantial additional infections: results from the first five months. Euro Surveill 2006; 11: E060608.3 [PMID: 16819119]
16. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662 [PMID: 19714720 DOI: 10.1002/hep.23190]
17. Obstetric group of the branch of obstetrics and gynecology in Chinese medical association. Clinical guidelines of prevent HBV mother-to-child transmission (first edition). Zhongguo Fuchanke Zazhi 2013; 48: 151-154 [DOI: 10.3760/cma.j.issn.0529-567x.2013.02.017]
18. Bzowej NH. Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant. Curr Hepat Rep 2012; 11: 82-89 [PMID: 22707918 DOI: 10.1007/s11901-012-0130-x]
19. The Antiretroviral Pregancy Registry Interim Report for 1 January 1989 through 31 July 2011. Available from: URL: http://www.apregistry.com/forms/interim-report.pdf
20. Munderi P, Wilkes H, Tumukunde D, Chidziva E, Nalumenya R, Gilks C, Zalwango E, Spyer M, Kyomugisha H, Lutwama F, Kikaire B, Kityo C, Reid A, Gibb D; DART Trial Team. Pregnancy rates and outcomes among women on triple-drug antiretroviral therapy in the DART trial [Poster WEPEB261]. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-22 July 2009, Cape Town, South Africa
21. Han GR, Xu CL, Zhao W, Yang YF. Management of chronic hepatitis B in pregnancy. World J Gastroenterol 2012; 18: 4517-4521 [PMID: 22969224 DOI: 10.3748/wjg.v18.i33.4517]
22. Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res 2010; 40: 31-48 [PMID: 20156298 DOI: 10.1111/j.1872-034X.2009.00597.x]
23. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S, Atkins M. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16: 94-103 [PMID: 19175878 DOI: 10.1111/j.1365-2893.2008.01056.x]
24. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45: 1056-1075 [PMID: 17393513 DOI: 10.1002/hep.21627]
25. Jiang HX, Han GR, Wang CM, Ji Y. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B]. Zhonghua Gan Zang Bing Zazhi 2012; 20: 888-891 [PMID: 23522247 DOI: 10.3760/cma.j.issn.1007-3418.2012.12.003]
26. Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011; 17: 4321-4333 [PMID: 22090789 DOI: 10.3748/wjg.v17.i38.4321]
27. Lok AS, Lai CL, Leung N, Yao GB, Cui ZY, Schiff ER, Dienstag JL, Heathcote EJ, Little NR, Griffiths DA, Gardner SD, Castiglia M. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology 2003; 125: 1714-1722 [PMID: 14724824 DOI: 10.1053/j.gastro.2003.09.033]
28. Zuckerman JN. Review: hepatitis B immune globulin for prevention of hepatitis B infection. J Med Virol 2007; 79: 919-921 [PMID: 17516515 DOI: 10.1002/jmv.20816]
29. Zhu Q, Lu Q, Gu XH, Duan SC, Xu HF, Zhang XZ, Dong ZS. A preliminary study on interruption of hepatitis B intrauterine transmission. Zhonghua Erke Zazhi 1995; 33: 93-94
30. Yuan J, Lin J, Xu A, Li H, Hu B, Chen J, Yao J, Dong H, Jiang M. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006; 13: 597-604 [PMID: 16907846 DOI: 10.1111/j.1365-2893.2006.00738.x]
31. Han ZH, Zhong LH, Wang J, Zhao QL, Sun YG, Li LW, Cao LH, Hao XC, Zhuang H. [The impact of antepartum injection of hepatitis B immunoglobulin on maternal serum HBV DNA and anti-HBs in the newborns]. Zhonghua Nei Ke Zazhi 2007; 46: 376-378 [PMID: 17637304 DOI: 10.3760/j.issn:0578-1426.2007.05.010]
32. Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007; 96: 167-170 [PMID: 17296201 DOI: 10.1016/j.ijgo.2006.11.011]
33. Hollinger FB. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 2007; 14 Suppl 1: 11-15 [PMID: 17958637 DOI: 10.1111/j.1365-2893.2007.00910.x]
34. Zhou YH, Hu YL. Effective strategy of prevent HBV mother-to-child transmission. Zhonghua Erke Zazhi 2010; 13: 273-276 [DOI: 10.3760/cma.j.issn.1007-9408.2010.04.003]
35. Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 2010; 14: e622-e634 [PMID: 20106694 DOI: 10.1016/j.ijid.2009.09.008]
36. Zeng XM, Men YL, Li R, Wang H, Zhao LS. Systematic review of hepatitis B immunoglobulin prevent HBV intrauterine transmission. Zhongguo Xunzheng Yixue Zazhi 2007; 7: 782-788 [DOI: 10.3969/j.issn.1672-2531.2007.11.006]
37. Li T, Qiu JM, Miao MH, Su XJ, Duan T. Meta-analysis on the effect of hepatitis B immunoglobulin on blocking intrauterine infection of HBV during the third-trimester. XianDai Fuke Jinzhan 2009; 18: 197-200
38. Trautwein C. Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation. J Hepatol 2004; 41: 362-369 [PMID: 15336437 DOI: 10.1016/j.jhep.2004.06.013]
39. Gan L, Liu DY, Wei M. Mutations of hepatitis B virus S gene by hepatitis B immunoglobulin administration in late pregnancy. Afr J Microbio Res 2012; 6: 5975-5979
40. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 2003; 9: 1501-1503 [PMID: 12854150]
41. Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities. Korean J Hepatol 2011; 17: 1-8 [PMID: 21494071 DOI: 10.3350/kjhep.2011.17.1.1]
42. Gupta I, Ratho RK. Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res 2003; 29: 84-86 [PMID: 12755527 DOI: 10.1046/j.1341-8076.2002.00076.x]
43. Duan WB, Wang BL, Zhou XP, Zhong YX. Anti-HBV immunoglobulin combined with hepatitis B vaccine in preventing intrauterine infection of HBV. Disi Junyi Daxue Xuebao 2005; 26: 191-192 [DOI: 10.3321/j.issn:1000-2790.2005.02.027]
44. Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl) 2002; 115: 1510-1512 [PMID: 12490098]
45. Yang J, Zeng XM, Men YL, Zhao LS. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus - a systematic review. Virol J 2008; 5: 100 [PMID: 18755018 DOI: 10.1186/1743-422X-5-100]
46. Fan Y, Xiao XM. Meta-analysis on the effect of delivery mode on maternal-infant transmission of hepatitis B virus. Zhongguo Fuyou Baojian 2007; 22: 3787-3789 [DOI: 10.3969/j.issn.1001-4411.2007.27.010]
47. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54: 1-31 [PMID: 16371945]
48. Huang L, Fan H, Ji B, Ye M. Research about the efficacy of delivery mode on maternal-infant transmission of hepatitis B virus. Zhongguo Xinyixue 2012; 43: 247-249 [DOI: 10.3989/g.issn.0253-9802.2012.04.012]
49. Petrova M, Kamburov V. Breastfeeding and chronic HBV infection: clinical and social implications. World J Gastroenterol 2010; 16: 5042-5046 [PMID: 20976840 DOI: 10.3748/wjg.v16.i40.5042]
50. Lin HH, Hsu HY, Chang MH, Chen PJ, Chen DS. Hepatitis B virus in the colostra of HBeAg-positive carrier mothers. J Pediatr Gastroenterol Nutr 1993; 17: 207-210 [PMID: 8229550 DOI: 10.1097/00005176-199308000-00014]
51. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002; 99: 1049-1052 [PMID: 12052598 DOI: 10.1016/S0029-7844(02)02000-8]
52. Zheng Y, Lu Y, Ye Q, Xia Y, Zhou Y, Yao Q, Wei S. Should chronic hepatitis B mothers breastfeed? a meta analysis. BMC Public Health 2011; 11: 502 [PMID: 21708016 DOI: 10.1186/1471-2458-11-502]
53. Wakabayashi H, Yamauchi K, Takase M. Inhibitory effects of bovine lactoferrin and lactoferricin B on Enterobacter sakazakii. Biocontrol Sci 2008; 13: 29-32 [PMID: 18432114 DOI: 10.4265/bio.13.29]
54. Li S, Zhou H, Huang G, Liu N. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin. Med Microbiol Immunol 2009; 198: 19-25 [PMID: 18810491 DOI: 10.1007/s00430-008-0100-7]
55. World Health Organization (WHO). Hepatitis B and breastfeeding. Update No. 22, November 1996. WHO Web Site (online), 2011. Available from: URL: http://www.who.int/child-adolescent-health/documents/pdfs/hepatitis-b-and-breastfeeding.pdf